Quantum Biopharma Cash Flow Statement (2019-2026) | QNTM

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-0.45M-0.44M-9.85M-3.32M2.09M3.35M4.02M-2.09M8.74M9.77M4.75M-2.30M13.75M
Share-based Compensation (Quarter)
3.02M0.25M0.34M0.08M0.36M0.59M0.51M3.21M0.40M0.13M0.10M0.06M0.11M0.07M-0.08M0.29M0.85M1.00M0.81M0.89M
Cash from Discontinued Operations (Quarter)
0.24M0.31M-2.61M-0.50M
Gains from Investment Securities (Quarter)
-0.29M-0.24M0.84M-0.24M0.58M0.04M-0.14M0.21M-0.33M0.01M0.11M-0.02M-0.01M74.000.03M3.11M7.55M1.25M-12.09M
Asset Writedowns and Impairment (Quarter)
0.48M3.84M0.24M
Non-cash Items (Quarter)
1.13M4.02M
Cash from Operations (Quarter)
6.58M4.59M-36.02M5.09M9.40M7.52M-50.34M-1.97M-0.61M-3.46M-0.84M-4.26M-1.95M-1.72M-0.31M-1.67M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.02M-0.02M0.01M0.33M0.12M0.01M0.01M
Depreciation & Amortization (CF) (Quarter)
0.98M1.00M1.10M1.13M1.15M1.13M1.11M0.15M0.12M0.14M0.12M0.13M0.14M0.15M0.13M
Change in Working Capital
Change in Receivables (Quarter)
0.29M-0.55M0.10M0.17M-0.53M0.63M-0.05M-0.05M0.06M0.17M-0.01M0.06M0.08M-0.02M-0.27M0.10M0.08M0.11M-0.10M0.02M
Change in Inventory (Quarter)
-0.12M0.02M0.02M-753.000.03M665.00
Change in Account Payables (Quarter)
2.08M-0.97M0.68M0.44M-0.24M-1.62M0.72M0.61M0.31M0.55M0.58M-1.05M1.03M1.16M3.13M-0.18M0.15M1.42M-0.21M-3.26M
Other Working Capital Changes (Quarter)
-0.41M-1.58M-0.04M0.20M-0.02M0.04M0.58M-0.37M0.33M0.15M0.19M-0.12M0.14M-0.02M0.08M-0.08M-0.31M0.41M0.02M-0.06M
Investing Activities
Capital Expenditures (Quarter)
0.05M-0.55M-0.01M-0.01M-0.10M0.23M-0.74M0.74M-0.02M222.00-3.46M3.49M-2.80M-1.45M-0.88M-2.96M
Change in Intangibles (Quarter)
0.27M0.09M1.75M0.39M0.07M
Divestments (Quarter)
-1.00M-0.11M-0.27M0.27M-0.02M0.74M-3.46M2.75M
Change in Acquisitions & Divestments (Quarter)
0.16M0.44M0.74M1.18M0.00M
Cash from Investing Activities (Quarter)
-0.11M11.91M-0.02M1.24M-1.35M0.35M-2.89M
Financing Activities
Other financing activities (Quarter)
0.01M0.01M0.05M-0.00M0.10M
Cash from Financing Activities (Quarter)
1.49M0.28M0.26M-4.09M0.57M1.84M6.74M2.47M3.13M1.29M0.26M1.41M7.00M
Change in Capital Stock
Net Shares Issued and Repurchased (Quarter)
1.47M0.23M0.22M-2.96M
Net Equity Issued and Repurchased (Quarter)
0.30M1.84M7.05M5.40M
Dividend Payments
Dividends Paid - Common (Quarter)
-6.64M-3.88M
Additional items
Exchange Rate Effect (Quarter)
-6.64M-0.20M31.82M0.49M0.17M-0.25M-1.65M1.11M-0.33M3.60M
Change in Cash (Quarter)
13.64M-21.58M6.69M-3.05M7.87M-29.79M-1.43M1.98M2.57M0.12M-2.48M-2.02M4.94M-4.54M2.44M
Beginning Cash Balance (Quarter)
35.26M16.98M2.76M6.00M1.91M
Free Cash Flow (Quarter)
6.58M4.54M-35.47M5.11M9.40M7.61M-50.57M0.74M-0.74M-1.95M-0.61M0.00M-4.32M-1.46M-0.50M-0.84M-0.31M1.29M
Net Cash Flow (Quarter)
6.58M4.59M-36.02M6.47M9.67M7.77M-42.52M-1.43M1.24M3.28M2.88M-2.48M-0.66M-1.46M1.46M2.44M